Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA Fragmentomics

NCT07684274 is registered in ClinicalTrials.gov with The First Affiliated Hospital with Nanjing Medical University as lead sponsor.

NCT NCT07684274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07684274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA Fragmentomics
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University
Phase
Observational
Overall status
Not yet recruiting
Start date
June 13, 2026
Completion date
December 31, 2027
Enrollment
290 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

mgus, multiple myeloma (mm), smoldering multiple myeloma (smm)